| Year |
Citation |
Score |
| 2020 |
Webster-Clark M, Jonsson Funk M, Stürmer T. Single-arm Trials With External Comparators and Confounder Misclassification: How Adjustment Can Fail. Medical Care. PMID 32925456 DOI: 10.1097/Mlr.0000000000001400 |
0.328 |
|
| 2020 |
Webster-Clark M, Stürmer T, Edwards JK, Poole C, Simpson RJ, Lund JL. Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults. Pharmacoepidemiology and Drug Safety. PMID 32666678 DOI: 10.1002/Pds.5069 |
0.309 |
|
| 2020 |
Stürmer T, Wang T, Golightly YM, Keil A, Lund JL, Jonsson Funk M. Methodological considerations when analysing and interpreting real-world data. Rheumatology (Oxford, England). 59: 14-25. PMID 31834408 DOI: 10.1093/Rheumatology/Kez320 |
0.314 |
|
| 2020 |
Lund JL, Webster-Clark M, Keil AP, Westreich D, Sturmer T, Sanoff HK. Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach. Journal of Clinical Oncology. 38: 7067-7067. DOI: 10.1200/Jco.2020.38.15_Suppl.7067 |
0.314 |
|
| 2019 |
Pratt NL, Mack CD, Meyer AM, Davis KJ, Hamill BG, Hampp C, Setoguchi S, Raman SR, Chun DS, Stürmer T, Lund JL. Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pharmacoepidemiology and Drug Safety. PMID 31736248 DOI: 10.1002/Pds.4924 |
0.538 |
|
| 2019 |
Wang T, Lu W, Li D, Tang H, Yang JY, Buse JB, Stürmer T. Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting. Diabetes Care. 42: e89-e91. PMID 31110120 DOI: 10.2337/Dc18-1609 |
0.317 |
|
| 2019 |
Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, Stürmer T. Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research. Gastrointestinal Endoscopy. PMID 31051156 DOI: 10.1016/J.Gie.2019.04.236 |
0.332 |
|
| 2019 |
Mayer SE, Tan HJ, Peacock Hinton S, Sanoff HK, Stürmer T, Hester LL, Faurot KR, Jonsson Funk M, Lund JL. Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients. Medical Care. PMID 30789540 DOI: 10.1097/Mlr.0000000000001073 |
0.318 |
|
| 2018 |
Wang T, Lu W, Tang H, Buse JB, Stürmer T, Gower EW. Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System. Diabetes Care. PMID 30530488 DOI: 10.2337/Dc18-1893 |
0.314 |
|
| 2018 |
Bushnell GA, Stürmer T, Mack C, Pate V, Miller M. Who diagnosed and prescribed what? Using provider details to inform observational research. Pharmacoepidemiology and Drug Safety. PMID 30379369 DOI: 10.1002/Pds.4685 |
0.54 |
|
| 2018 |
Hong JL, Buse JB, Jonsson Funk M, Pate V, Stürmer T. The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults. Diabetes Care. PMID 29618573 DOI: 10.2337/Dc17-2212 |
0.306 |
|
| 2017 |
Pottegård A, Friis S, Stürmer T, Hallas J, Bahmanyar S. Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations. Basic & Clinical Pharmacology & Toxicology. PMID 29265740 DOI: 10.1111/Bcpt.12946 |
0.31 |
|
| 2017 |
Kinlaw AC, Stürmer T, Lund JL, Pedersen L, Kappelman MD, Daniels JL, Frøslev T, Mack CD, Sørensen HT. Trends in Antibiotic Use by Birth Season and Birth Year. Pediatrics. PMID 28808074 DOI: 10.1542/Peds.2017-0441 |
0.555 |
|
| 2017 |
Garry EM, Buse JB, Lund JL, Pate V, Stürmer T. Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives on the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes. Diabetes, Obesity & Metabolism. PMID 28661561 DOI: 10.1111/Dom.13049 |
0.32 |
|
| 2017 |
Thygesen LC, Pottegård A, Ersbøll AK, Friis S, Stürmer T, Hallas J. External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk. British Journal of Clinical Pharmacology. PMID 28599067 DOI: 10.1111/Bcp.13342 |
0.311 |
|
| 2017 |
Gokhale M, Buse JB, Jonsson Funk M, Lund J, Pate V, Simpson RJ, Stürmer T. No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase 4 inhibitors versus therapeutic alternatives. Diabetes, Obesity & Metabolism. PMID 28195389 DOI: 10.1111/Dom.12906 |
0.339 |
|
| 2016 |
Noordam R, Sitlani CM, Avery CL, Stewart JD, Gogarten SM, Wiggins KL, Trompet S, Warren HR, Sun F, Evans DS, Li X, Li J, Smith AV, Bis JC, Brody JA, et al. A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Journal of Medical Genetics. PMID 28039329 DOI: 10.1136/Jmedgenet-2016-104112 |
0.302 |
|
| 2016 |
Floyd JS, Sitlani CM, Avery CL, Noordam R, Li X, Smith AV, Gogarten SM, Li J, Broer L, Evans DS, Trompet S, Brody JA, Stewart JD, Eicher JD, Seyerle AA, et al. Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. The Pharmacogenomics Journal. PMID 27958378 DOI: 10.1038/Tpj.2016.90 |
0.324 |
|
| 2016 |
Young JC, Stürmer T, Lund JL, Jonsson Funk M. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data. Pharmacoepidemiology and Drug Safety. PMID 26991151 DOI: 10.1002/Pds.3991 |
0.314 |
|
| 2016 |
Lund JL, Sturmer T, Sanoff HK. Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy. Journal of Geriatric Oncology. PMID 26926829 DOI: 10.1016/J.Jgo.2016.01.011 |
0.305 |
|
| 2015 |
Bis JC, Sitlani C, Irvin R, Avery CL, Smith AV, Sun F, Evans DS, Musani SK, Li X, Trompet S, Krijthe BP, Harris TB, Quibrera PM, Brody JA, Demissie S, et al. Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium. Plos One. 10: e0140496. PMID 26516778 DOI: 10.1371/Journal.Pone.0140496 |
0.332 |
|
| 2015 |
Mack CD, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. Epidemiology (Cambridge, Mass.). 26: 690-9. PMID 26196683 DOI: 10.1097/Ede.0000000000000355 |
0.584 |
|
| 2015 |
Wyss R, Ellis AR, Brookhart MA, Jonsson Funk M, Girman CJ, Simpson RJ, Stürmer T. Matching on the disease risk score in comparative effectiveness research of new treatments. Pharmacoepidemiology and Drug Safety. PMID 26112690 DOI: 10.1002/Pds.3810 |
0.31 |
|
| 2015 |
Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ. Metformin and the risk of endometrial cancer: a population-based cohort study. Gynecologic Oncology. 136: 341-7. PMID 25499603 DOI: 10.1016/J.Ygyno.2014.12.001 |
0.34 |
|
| 2015 |
Brouwer ES, Napravnik S, Eron JJ, Simpson RJ, Brookhart MA, Stalzer B, Vinikoor M, Floris-Moore M, Stürmer T. Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical Cohort. Medical Care. 53: e41-8. PMID 23604043 DOI: 10.1097/Mlr.0B013E318287D6Fd |
0.658 |
|
| 2015 |
Riss AH, Johansen MB, Brookhart MA, Stürmer T, Støvring H. The Apparent Effect of Oral Contraceptives on the Risk of Venous Thromboembolism Depends on the Length of the Look-Back Period Pharmacoepidemiology and Drug Safety. 24. DOI: 10.1002/Pds.3838 |
0.324 |
|
| 2014 |
Gokhale M, Buse JB, Gray CL, Pate V, Marquis MA, Stürmer T. Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: A cohort study Diabetes, Obesity and Metabolism. 16: 1247-1256. PMID 25109825 DOI: 10.1111/Dom.12379 |
0.33 |
|
| 2014 |
Miller M, Swanson SA, Azrael D, Pate V, Stürmer T. Antidepressant dose, age, and the risk of deliberate self-harm. Jama Internal Medicine. 174: 899-909. PMID 24782035 DOI: 10.1001/Jamainternmed.2014.1053 |
0.308 |
|
| 2014 |
Brouwer ES, Napravnik S, Eron JJ, Stalzer B, Floris-Moore M, Simpson RJ, Stürmer T. Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients. Epidemiology (Cambridge, Mass.). 25: 406-17. PMID 24713880 DOI: 10.1097/Ede.0000000000000041 |
0.675 |
|
| 2013 |
Le HV, Poole C, Brookhart MA, Schoenbach VJ, Beach KJ, Layton JB, Stürmer T. Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. Bmc Medical Research Methodology. 13: 142. PMID 24245772 DOI: 10.1186/1471-2288-13-142 |
0.558 |
|
| 2013 |
Dusetzina SB, Mack CD, Stürmer T. Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics. Plos One. 8: e63973. PMID 23667693 DOI: 10.1371/Journal.Pone.0063973 |
0.578 |
|
| 2013 |
Layton JB, Kshirsagar AV, Simpson RJ, Pate V, Jonsson Funk M, Stürmer T, Brookhart MA. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. The American Journal of Cardiology. 111: 823-8. PMID 23273532 DOI: 10.1016/J.Amjcard.2012.11.047 |
0.32 |
|
| 2013 |
O'Brien EC, Rose KM, Suchindran CM, Sturmer T, Chang PP, Alonso A, Baggett CD, Rosamond WD. Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study). The American Journal of Cardiology. 111: 305-11. PMID 23168284 DOI: 10.1016/J.Amjcard.2012.09.032 |
0.305 |
|
| 2013 |
Mack C, Brookhart M, Glynn R, Stürmer T. Calendar Time As An Instrumental Variable In Nonexperimental Comparative Effectiveness Research Of Emerging Therapies Value in Health. 16: A129-A130. DOI: 10.1016/J.Jval.2013.03.629 |
0.553 |
|
| 2011 |
Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiology and Drug Safety. 20: 551-9. PMID 21394812 DOI: 10.1002/Pds.2098 |
0.302 |
|
| 2010 |
Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. American Journal of Epidemiology. 172: 843-54. PMID 20716704 DOI: 10.1093/Aje/Kwq198 |
0.301 |
|
| 2010 |
Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Medical Care. 48: S114-20. PMID 20473199 DOI: 10.1097/Mlr.0B013E3181Dbebe3 |
0.309 |
|
| 2008 |
Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis and Rheumatism. 59: 1097-104. PMID 18668605 DOI: 10.1002/Art.23911 |
0.353 |
|
| 2008 |
Stürmer T, Rothman KJ, Avorn J. Pharmacoepidemiology and "in silico" drug evaluation: is there common ground? Journal of Clinical Epidemiology. 61: 205-6. PMID 18226742 DOI: 10.1016/J.Jclinepi.2007.07.006 |
0.344 |
|
| 2007 |
Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information Medical Care. 45: S158-S165. PMID 17909375 DOI: 10.1097/Mlr.0B013E318070C045 |
0.335 |
|
| 2007 |
Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results Medical Care. 45: S131-S142. PMID 17909372 DOI: 10.1097/Mlr.0B013E318070C08E |
0.352 |
|
| 2007 |
Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Performance of propensity score calibration - A simulation study American Journal of Epidemiology. 165: 1110-1118. PMID 17395595 DOI: 10.1093/Aje/Kwm074 |
0.304 |
|
| 2007 |
Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Stürmer et al. respond to "propensity score methods in epidemiology" American Journal of Epidemiology. 165: 1122-1123. DOI: 10.1093/Aje/Kwm068 |
0.306 |
|
| 2006 |
Stürmer T, Hasselbach P, Amelang M. Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort Bmj. 332: 1359-1362. PMID 16687457 DOI: 10.1136/Bmj.38833.479560.80 |
0.31 |
|
| 2006 |
Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis and Rheumatism. 54: 1378-89. PMID 16645966 DOI: 10.1002/Art.21887 |
0.317 |
|
| 2006 |
Stürmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods Journal of Clinical Epidemiology. 59: 437.e1-437.e24. PMID 16632131 DOI: 10.1016/J.Jclinepi.2005.07.004 |
0.306 |
|
| 2005 |
Stürmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. American Journal of Epidemiology. 162: 279-89. PMID 15987725 DOI: 10.1093/Aje/Kwi192 |
0.323 |
|
| 2005 |
Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: Nonsteroidal antiinflammatory drugs and short-term mortality in the elderly American Journal of Epidemiology. 161: 891-898. PMID 15840622 DOI: 10.1093/Aje/Kwi106 |
0.339 |
|
| 2004 |
Stürmer T, Glynn RJ. S20.3: Risk for Colorectal Cancer After Initiation of Regular Nonsteroidal Anti‐inflammatory Drug Use: Post‐Trial Follow‐up Data from the Physicians' Health Study Biometrical Journal. 46: 43-43. DOI: 10.1002/Bimj.200490246 |
0.306 |
|
| Show low-probability matches. |